• Most Popular
  • Most Shared

Innogenetics secures key hepatits B testing patent

Wed Feb 6, 2008 11:58am EST

BRUSSELS, Feb 6 (Reuters) - Belgian biotech company Innogenetics INNX.BR said on Wednesday it had secured a key patent from the United States Patent Office for hepatitis B drug resistance testing.

"This is the first granted US patent covering a critical mutation leading to hepatitis B viral drug resistance," Innogenetics said in a statement.

It said drug resistance testing was now highly recommended for all available hepatitis B antivirals such as lamivudine, adefovir, and entecavir. The patent broadened Innogenetics' patent position in the field for at least 10 years, it added. (Reporting by Philip Blenkinsop; Editing by Ingrid Melander)



More from Reuters

Photo

Obama says U.S. will pursue plane attackers

KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video

» More Top News
Passengers queue to go through security checks at the departure gate at Gatwick Airport, in southern England December 28, 2009. REUTERS/Luke MacGregor

Travel headaches after scare

The U.S. is stepping up airline security measures following the Christmas bomb scare. Here's what you can expect.  Full Article | Video 

U.S.
Iranian protesters take a policeman away to a safe place after he was beaten by angry protesters during fierce clashes in central Tehran December 27, 2009. Credit: REUTERS/Stringer

Deaths, arrests in Iran

Is Iran's "iron fist of brutality" a new volatile phase aimed at crushing the refomist movement?  Full Article | Video 

World